CHD Bioscience

Chd Bioscience

Biotechnology, 2950 E Harmony Rd, Fort Collins, Colorado, 80528, United States, 11-50 Employees

chdbioscience.com

  • LinkedIn

phone no Phone Number: 97********

Who is CHD BIOSCIENCE

CHD Bioscience is a multi-product development-stage healthcare company that has created a technology platform to stem the rising tide of drug-resistant pathogens by creating unique topica...

Read More

map
  • 2950 E Harmony Rd, Fort Collins, Colorado, 80528, United States Headquarters: 2950 E Harmony Rd, Fort Collins, Colorado, 80528, United States
  • 2011 Date Founded: 2011
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 1541

checked-icon Does something look wrong? Fix it. | View contact records from CHD BIOSCIENCE

CHD Bioscience Org Chart and Mapping

Employees

John Skinner

Manager of Research & Development

Verda Parisi

Human Resource Executive

Edwin Neas

Senior V.P. Chd Bioscience

Cathleen Zimmerman

Quality Assurance/Regulatory Specialist

Patrick Handley

Technical Operations Manager

Blair Ives

Human Resource Executive

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding CHD Bioscience

Answer: CHD Bioscience's headquarters are located at 2950 E Harmony Rd, Fort Collins, Colorado, 80528, United States

Answer: CHD Bioscience's phone number is 97********

Answer: CHD Bioscience's official website is https://chdbioscience.com

Answer: CHD Bioscience's revenue is $5 Million to $10 Million

Answer: CHD Bioscience's SIC: 1541

Answer: CHD Bioscience has 11-50 employees

Answer: CHD Bioscience is in Biotechnology

Answer: CHD Bioscience contact info: Phone number: 97******** Website: https://chdbioscience.com

Answer: CHD Bioscience is a multi-product development-stage healthcare company that has created a technology platform to stem the rising tide of drug-resistant pathogens by creating unique topical therapeutics for unmet medical needs in the dermal and orthopedic markets. CHD technology is focused on serious, unmet medical needs in the following markets: Wound Care (wound dressings and bandages, wound gels, wound washes and instillation products and coated internal surgical meshes), Orthopedics (orthopedic coatings, orthopedic flushing solutions) and Therapeutic Topical Soft Tissue Infections (Topical products for skin and structural skin infections). CHD's first generation agent, VERIOX, is a novel, anti-microbial agent with demonstrated unique safety and efficacy properties which can mitigate the increasing threat of pathogens such as MRSA, CRE, VRE and C. difficile spores.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access